PF-06260414

DB15221InvestigationalSmall molecule

PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects).

Formula / weight: C₁₄H₁₄N₄O₂S · 302.35 g/mol (avg)
Code names: PF-06260414

Resolves to

Compound

UNII3I487UHH95CAS1612755-71-1

Structure

InChIKeyZKAVFOXYJCREBQ-SNVBAGLBSA-NSMILESC[C@@H]1CNS(=O)(=O)N(C1)C1=CC2=CC=NC(C#N)=C2C=C1

Targets

P10275AR

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with PF-06260414, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account